Saudi, British FMs discuss regional developments in phone call    Saudi Arabia unveils new skill-based system for expatriate work permits Classification for existing workers began on June 18 while July 1 set for newcomers    New Saudi embassy building inaugurated in Moscow    Nearly 17 million foreign pilgrims perform Umrah in 2024, up 101% from 2022 Makkah ranks 5th globally in number of international visitors    Saudi Arabia reaffirms dedication to achieving equitable and sustainable digital development    Over 80,000 commercial registrations issued in 2Q 2025, bringing total to 1.7 million    Elon Musk announces launch of new political party amid fallout with Trump    UK Foreign Secretary makes historic visit to Syria    Khamenei makes first public appearance since Iran–Israel war    Desperate search continues as Texas flood kills 51, including 15 children 27 girls from summer camp still missing    Riot Games responds to match-fixing allegations in VALORANT    BLAST responds to BESTIA Visa controversy ahead of CS2 Austin major    Christophe Galtier named NEOM SC head coach ahead of historic Saudi Pro League debut    Level Up Docuseries launches June 6 on Prime Video    OPEC+ further accelerates oil output hike by 548,000 bpd in August    Saudi Arabia tops global ICT Development Index for 2025    Michael Madsen, actor of 'Kill Bill' and 'Reservoir Dogs' fame, dead at 67    BTS are back: K-pop band confirm new album and tour    Michelin Guide launches in Saudi Arabia with phased rollout in 2025    'How fragile we are': Roskilde Festival tragedy remembered 25 years on    Sholay: Bollywood epic roars back to big screen after 50 years with new ending    Ministry launches online booking for slaughterhouses on eve of Eid Al-Adha    Shah Rukh Khan makes Met Gala debut in Sabyasachi    Pakistani star's Bollywood return excites fans and riles far right    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Study raises hope for safer diabetes drugs
Published in Saudi Press Agency on 21 - 07 - 2010

A new understanding of the link between diabetes and obesity may help drug companies design safer versions of treatments like GlaxoSmithKline's Avandia, Reuters cited U.S. researchers as saying today.
The researchers had believed Avandia and Takeda Pharmaceutical Co's Actos work by stimulating a protein known as PPAR-gamma. Now the team thinks the drugs also act on the insulin resistance that diabetics develop through a different route.
And they think it may be possible to tinker with drugs in this class to overcome some of their side effects.
"Our findings strongly suggest that good and bad effects of these drugs can be separated by designing second-generation drugs that focus on the newly uncovered mechanism," Bruce Spiegelman of Dana-Farber Cancer Institute in Boston, who worked on the study in the journal Nature, said in a statement.
Avandia and Actos, known generically as rosiglitazone and pioglitazone, are widely used to offset obesity-related changes in a person's insulin response that lead to diabetes.
Both drugs increase the risk of fractures and heart failure, and several reports have linked Avandia with an increased risk of heart attacks and strokes.
This month an advisory panel to the U.S. Food and Drug Administration found data that raised concerns about heart attacks associated with Avandia, but not enough to warrant its withdrawal from the market.
The drugs act on a protein called PPAR-gamma, found mostly in fat cells, that regulates genes involved in the body's response to insulin.
Scientists had believed the drugs work by stimulating PPAR-gamma, causing it to increase the activity of some genes and dampen others. The Dana-Farber researchers and a team from The Scripps Research Institute in California now think the drugs work in a different way.
In studies in obese mice, they found obesity activates a molecular switch called cdk5, which causes a chemical change in PPAR-gamma, triggering resistance to insulin and increasing blood sugar levels.
They did studies in cells and a test tube and found that drugs like Avandia and Actos block changes in cdk5 in addition to stimulating PPAR-gamma.
"That suggested a completely new model for how these drugs were working," Spiegelman said in a telephone interview.
He thinks drug companies might be able to design more selective diabetes drugs that treat insulin resistance without stimulating PPAR-gamma, which Spiegelman thinks is responsible for the side effects seen in Actos and Avandia.


Clic here to read the story from its source.